The arbitration against Mylan continues to progress and it is worth noting Mylan has not submitted any counterclaims. The hearing is scheduled for fourth quarter 2017.
Possible settlement?
Multiple new TPM®/Oxymorphone patch candidates are on track towards stability testing in third quarter 2016.
Given that there’s only one month remaining in this quarter, it looks like tesa Labtec have been successful in coming up with multiple viable patch candidates.
- Forums
- ASX - By Stock
- Ann: Phosphagenics Half Year Financial Results-POH.AX
The arbitration against Mylan continues to progress and it is...
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVE (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.923M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $2.588K | 1.035M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
53 | 94288418 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 76366017 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
53 | 94288418 | 0.002 |
18 | 77595009 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 76366017 | 22 |
0.004 | 17087707 | 16 |
0.005 | 22033532 | 10 |
0.006 | 19255067 | 9 |
0.007 | 5722471 | 6 |
Last trade - 14.43pm 03/09/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |